@article{374cc63756b94a83be9b034924b90e77,
title = "Correction to: Osimertinib in poor performance status patients with T790M‑positive advanced non‑small‑cell lung cancer after progression of first- and second‑generation EGFR‑TKI treatments (NEJ032B) (International Journal of Clinical Oncology, (2022), 27, 1, (112-120), 10.1007/s10147-021-02043-2)",
abstract = "In the original publication, the name of ninth author was mistakenly published as: Satoshi Ohizumi. The correct name is: Satoshi Oizumi as given in this Correction.",
author = "Yukari Tsubata and Kana Watanabe and Ryota Saito and Atsushi Nakamura and Hiroshige Yoshioka and Mami Morita and Ryoichi Honda and Nobuhiro Kanaji and Satoshi Oizumi and Daisuke Jingu and Taku Nakagawa and Kensuke Nakazawa and Atsuto Mouri and Susumu Takeuchi and Naoki Furuya and Yuki Akazawa and Kiyotaka Miura and Eiki Ichihara and Makoto Maemondo and Satoshi Morita and Kunihiko Kobayashi and Takeshi Isobe",
note = "Publisher Copyright: {\textcopyright} The Author(s) under exclusive licence to Japan Society of Clinical Oncology 2022.",
year = "2022",
month = apr,
doi = "10.1007/s10147-022-02118-8",
language = "English",
volume = "27",
pages = "823--824",
journal = "International Journal of Clinical Oncology",
issn = "1341-9625",
publisher = "Springer Japan",
number = "4",
}